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Abstract
Introduction: Acute kidney injury (AKI) is common after cardiac operations. There are different risk factors or
determinants of AKI, and some are related to cardiopulmonary bypass (CPB). In this study, we explored the
association between metabolic parameters (oxygen delivery (DO2) and carbon dioxide production (VCO2)) during
CPB with postoperative AKI.
Methods: We conducted a retrospective analysis of prospectively collected data at two different institutions. The
study population included 359 adult patients. The DO2 and VCO2 levels of each patient were monitored during
CPB. Outcome variables were related to kidney function (peak postoperative serum creatinine increase and AKI
stage 1 or 2). The experimental hypothesis was that nadir DO2 values and nadir DO2/VCO2 ratios during CPB would
be independent predictors of AKI. Multivariable logistic regression models were built to detect the independent
predictors of AKI and any kind of kidney function damage.
Results: A nadir DO2 level < 262 mL/minute/m
2 and a nadir DO2/VCO2 ratio < 5.3 were independently associated
with AKI within a model including EuroSCORE and CPB duration. Patients with nadir DO2 levels and nadir DO2/VCO2
ratios below the identified cutoff values during CPB had a significantly higher rate of AKI stage 2 (odds ratios 3.1 and
2.9, respectively). The negative predictive power of both variables exceeded 90%. The most accurate predictor of AKI
stage 2 postoperative status was the nadir DO2 level.
Conclusions: The nadir DO2 level during CPB is independently associated with postoperative AKI. The
measurement of VCO2-related variables does not add accuracy to the AKI prediction. Since DO2 during CPB is a
modifiable factor (through pump flow adjustments), this study generates the hypothesis that goal-directed
perfusion management aimed at maintaining the DO2 level above the identified critical value might limit the
incidence of postoperative AKI.
Introduction
After cardiac surgery, renal function impairment is com-
mon, and acute kidney injury (AKI) has an incidence
that may reach 50% according to some definitions [1].
The early mortality rate in patients with AKI is around
5% but climbs to 50% when renal replacement therapy
is required [2-4]. Various factors related to cardiopul-
monary bypass (CPB) have been implicated as possible
determinants of AKI. They include CPB duration [2,5,6],
low perfusion pressure [7], low pump flow [7,8], severe
haemodilution [8-11] and low oxygen delivery (DO2) [8].
In 2005, in a retrospective series, we demonstrated that a
lowest (nadir) DO2 level of 272 mL/minute/m
2 during CPB
was independently associated with acute renal failure and
peak postoperative serum creatinine levels [8]. Subse-
quently, we identified that DO2 levels < 260 mL/minute/m
2
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during CPB were associated with increased lactate forma-
tion [12] and that hyperlactatemia was associated with
decreased DO2 levels and an increased CO2 production
(VCO2) during CPB, with critical values settled at a VCO2
> 60 mL/minute/m2 and a DO2/VCO2 ratio < 5.0 [13].
These data generate the hypothesis that when the DO2
during CPB falls below a critical value (in the range of 260
to 270 mL/minute/m2), organ dysoxia may be triggered,
with consequent tissue acidosis leading to increased
VCO2, and that this mechanism may be a determinant of
impaired postoperative renal function.
Despite this information, routine measurement of DO2
and VCO2 is still not the standard of care during CPB.
The quality indicators used for CPB management are
wide-ranging and are mostly ‘stand alone’ parameters.
There is little or no evidence in the literature to suggest
that goal-directed perfusion pressure using current quality
indicators [14] influences clinical outcomes. The finding
that low DO2 during CPB is an independent determinant
of postoperative AKI is still based on a single-centre
observation.
In the present dual-centre large series of patients where
these values were routinely monitored during CPB, we
investigated the hypothesis that DO2 and VCO2 during
CPB might be independently associated with postoperative
AKI.
Materials and methods
In this retrospective analysis of prospectively collected
data collected at two institutions (Heart Centre, Universi-
tair Ziekenhuis Gent, Gent, Belgium, and Department of
Cardiothoracic Surgery, Essex Cardiothoracic Centre, Lon-
don, UK) DO2 and VCO2 measurement were introduced
as part of standard monitoring during CPB in 2009. The
primary end point of this study was the determination
whether the nadir DO2 value and DO2/VCO2 ratio and
the VCO2 peak value during CPB are independently asso-
ciated with postoperative renal function impairment,
which we defined as the peak postoperative serum creati-
nine value and the presence of AKI according to the AKI
Network (AKIN) criteria [15]. Briefly, a patient was
assigned to the AKI stage 1 group based on an increase in
peak postoperative serum creatinine greater than or equal
to 150% to 200% from the baseline value and to the AKI
stage 2 group based on an increase in peak postoperative
serum creatinine to more than 200% to 300% from the
baseline value. Patients assigned to AKI stage 3 (peak post-
operative serum creatinine value more than three times
the baseline value) were identified but included in the AKI
stage 2 group because of the predictable low rate of events.
According to the AKIN criteria, the assignment of patients
to the different AKI stages was based on creatinine
changes only, and urine output was not considered. Crea-
tinine changes were recorded within the first 48 hours
after the operation. The secondary end point was explor-
ing the association of the same DO2- and VCO2-related
variables with general outcome measurements (length of
ICU and postoperative hospital stays).
The study was approved by the local ethics committee
and the institutional review boards of the two participat-
ing institutions (Local Ethics Committee Universitair
Ziekenhuis Gent, Gent, Belgium, registration number
B670201010162; Institutional Review Board Basildon
University Hospital, Nethermayne, Basildon, Essex,
SS165NL, UK), and the need for written informed con-
sent from the patients was waived.
Patients
Three hundred fifty-nine patients (Gent: 223; London:
136) who had surgery between September 2009 and June
2010 were admitted into the study. Entry criteria were
patient age > 18 years undergoing CPB and expected
CPB duration > 90 minutes. Exclusion criteria were the
presence of chronic renal failure being treated with dialy-
sis and patients who had undergone heart or heart and
lung transplantation.
The patients were consecutively enrolled at both Insti-
tutions. Since only one dedicated software system was
available for data collection at each Institution, some
patients were not included in cases where two operations
were being performed simultaneously on two suitable
candidates for enrolment. This criterion accounted for a
missing cases rate of 23%. The patients included in the
present series were not included in the previous studies
dealing with the same experimental hypothesis.
Sample size
Power analysis was performed before retrospective data
collection. On the basis of historical data from the two
institutions, the postoperative AKI stage 2 rate was calcu-
lated as 12%. The ratio of patients with low DO2 (< 260
mL/minute/m2) was calculated as 35%. The study was
powered to detect a double AKI stage 2 rate in patients
with low DO2. Considering the unequal distribution of
patients with low and high DO2, an a value of 0.05 and a
b value of 0.20, the following sample size was calculated:
(1) 195 patients with high DO2 (65%) comprising 18
patients with AKI (9%) and (2) 105 patients with low DO2
(35%) comprising 18 patients with AKI (17%). The total
patient population included in the study was therefore
between 300 and 400 patients to account for possible lack
of data during the study period.
Data collection and definitions
The following data were recorded for all patients.
1. Preoperative data: Patient demographics, baseline
serum creatinine level (mg/dL), estimated creatinine clear-
ance (measured using the Cockcroft-Gault equation), left
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ventricular ejection fraction (%), comorbidities (diabetes,
chronic obstructive pulmonary disease, previous cerebro-
vascular accident), baseline haemoglobin (Hb) value
(g/dL), logistic EuroSCORE and acute renal failure risk
according to a validated risk score [6].
2. Perioperative data: Reoperation, type of operation,
CPB duration, nadir body temperature (°C) during CPB,
nadir haematocrit (HCT) level (%) (measured at the start
of the CPB operation and every 20 minutes thereafter),
nadir DO2 (mL/minute/m
2), peak VCO2 (mL/minute/m
2)
and nadir DO2/VCO2 ratio during CPB, peak serum lac-
tate during CPB and number of packed red cell (PRC)
units transfused during CPB.
3. Postoperative data: Peak serum creatinine level
(mg/dL), peak postoperative change in creatinine level
(percentage change from baseline), estimated lowest crea-
tinine clearance, AKI stage defined according to the AKIN
criteria, number of PRC units transfused and days spent in
the ICU and postoperatively in the hospital.
The number of PRC units transfused was considered as
a potential risk factor for renal function impairment. Since
transfusions may be the consequence rather than the
cause of renal dysfunction, we considered the number of
PRC units transfused before the onset of the renal dys-
function (perioperatively or soon after surgery).
Cardiopulmonary bypass technique
All patients were treated with moderately hypothermic
CPB (27°C to 36°C). The CPB circuit consisted of an
Avant oxygenator (Sorin Group, Mirandola, Italy), an
HVR Evo hard-shell reservoir (Sorin Group) in London
and a closed CVR 1200 soft-shell reservoir (Sorin Group)
in Gent, Belgium. The hardware consisted of a Stöckert S5
heart-lung machine (Sorin Group) and a Stöckert Heater
Cooler System 3T (Sorin Group).
Priming solutions consisted of 1,400 mL of Hartmann’s
solution and 10,000 IU of heparin (London site) and
1,200 mL of gelatine (1,000 mL), 15% mannitol (200 mL)
and 2,500 IU of heparin (Gent site). No hydroxyethyl
starch was used for priming the circuit or as additional
fluid during CPB. Cardioplegic solution was a 4:1 ratio of
cold blood cardioplegia (St. Thomas’s solution) at an
induction dose of 1,000 mL, with subsequent 200-mL
doses every 20 minutes of (London site) and 800- to
1000-mL single-dose Saint Thomas II crystalloid cardio-
plegia with additional doses if considered necessary by the
surgeon (Gent site). Pump flow was settled at 2.4 to
2.8 L/minute/m2 at the outset of CPB and subsequently
adjusted according to the patient’s core temperature
(usually a 20% decrease for core temperatures between
30°C and 34°C and an additional 10% decrease for
core temperatures < 30°C). A Hb value less than 6 to
7 g/dL during CPB was considered the trigger point for
PRC transfusion. All patients received tranexamic acid
according to the routine protocol of each institution, and
no aprotinin was used.
Oxygen- and carbon dioxide-related measurements
DO2- and VCO2-related measurements were performed
using a dedicated software system provided by Dideco
(Sorin Group). Data were collected at 10-minute intervals
during CPB. Data required to calculate DO2 and VCO2
were arterial Hb (g/dL), pump flow (L/minute/m2), arterial
O2 saturation, gas flow into the oxygenator (L/minute)
and expiratory CO2 tension (mmHg) measured at the site
of the oxygenator exhaled gas port with a Datex-Ohmeda
capnograph (GE Healthcare, Little Chalfont, UK)), or with
a ventilator-integrated capnograph.
All blood gas data were corrected for temperature by
using standard equations. The equations used to deter-
mine DO2 and VCO2 were described in a previous article
[13]. Briefly, DO2 was calculated using the following
equation:
DO2(mL/minute/m2) = 10×pump flow (L/minute/m2)×arterial O2content (mL/100 mL),
where arterial O2 content was calculated as follows:
Arterial O2 content (mL/100 mL) = Hb (mg/dL) ×
1.34 × Hb saturation (%) + 0.003 × O2 tension (mmHg).
VCO2 was calculated using the following equation:
VCO2 (mL/minute/m2) = eCO2 (mmHg)× Ve (L/minute)× 1, 000
760× body surface area (m2).
Gas volume and flow are expressed as dry standard
temperature and pressure. Adequate corrections accord-
ing to body temperature and pressure saturated condi-
tions were applied.
The nadir DO2 level was defined as the lowest DO2
value registered for at least two consecutive measure-
ments, the peak VCO2 value was defined as the highest
VCO2 level registered for at least two consecutive mea-
surements and the nadir DO2/VCO2 ratio was defined as
the lowest value registered for at least the two consecutive
measurements. The normal DO2 and VCO2 values in
healthy, awake subjects are usually around 500 mL/min-
ute/m2 and 100 mL/minute/m2, respectively. Under mod-
erate hypothermia, anaesthesia and haemodilution during
CPB, these values are always reduced to unspecified
values.
Statistical analysis
Data are expressed as means ± standard deviation (nor-
mally distributed continuous variables) or as frequencies
and percentages (categorical variables). Nadir DO2,
nadir DO2/VCO2 ratio and peak VCO2 during CPB
were tested for association with kidney function vari-
ables using bivariate linear regression analysis (for peak
postoperative serum creatinine) or bivariate logistic
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regression analysis (for AKI stage 1 or 2 and any kind of
AKI). Other possible confounders were tested for asso-
ciations with kidney function variables using the same
technique. The linearity assumption was checked by
exploring the decile-based distribution of the AKI stage
2 rate with spline curves. For the independent predictors
of AKI, adequate cutoff values were identified using a
receiver operating characteristic (ROC) curve, and the
area under the curve (AUC) was used to determine the
accuracy of the model. The cutoff values were chosen
according to Youden’s index (best sensitivity value +
(specificity - 1)). For each cutoff value, the sensitivity,
specificity and negative and positive predictive values
were measured.
All the factors associated (P < 0.1) with AKI stage 2 or
any kind of AKI were entered into multivariable stepwise
forward logistic regression models for definition of the
independent predictors of kidney function impairment to
generate odds ratios with 95% confidence intervals. To
avoid overfitting of the models, only one independent vari-
able per 10 events was entered into the model. To avoid
multicollinearity, variables affected by mathematical cou-
pling were separately entered into different models. In
cases of intercorrelation, the best single independent vari-
able was chosen. For all the statistical tests, a P value <
0.05 was considered significant. Data analysis was per-
formed using SPSS 13.0 statistical software (SPSS Inc.,
Chicago, IL, USA).
Results
The demographics, preoperative, operative and postopera-
tive details of the patient population are shown in Table 1.
In our patient population (N = 359), we identified 31
patients (8.6%) with AKI stage 1 and 44 patients (12.2%)
with AKI stage 2, for a total of 75 patients (21%) with any
kind of AKI. Within the AKI stage 2 group, five patients
(1.4%) with AKI stage 3 were included.
The variables listed in Table 1 were tested for univariate
association with the renal function outcomes (Table 2).
The effect of the cardiac surgery centre on renal outcomes
was analysed. Centre, patient age, diabetes, reoperation,
EuroSCORE, combined coronary and valve operation,
CPB duration, number of PRC units transfused and the
three study variables nadir DO2, peak VCO2 and nadir
DO2/VCO2 ratio during CPB were all associated with
renal outcomes and were therefore admitted into the fol-
lowing multivariable analyses. The other perioperative
variables were not significantly associated with renal
outcomes.
To check the linearity of the relationship between
nadir DO2 levels and nadir DO2/VCO2 ratios with post-
operative AKI stage 2, we explored the rate of AKI stage
2 outcomes according to the decile distribution of the
two independent variables. The graphical analysis of the
AKI stage 2 rate according to nadir DO2 level and DO2/
VCO2 ratio during CPB (Figures 1 and 2) demonstrated
a nonlinearity of the association.
We therefore decided to explore the adequate cutoff
values for nadir DO2 level and nadir DO2/VCO2 ratio
during CPB as possible predictors of postoperative AKI
stage 2 and to include those values in the subsequent
multivariable analysis. ROC curves were analysed for
nadir DO2 levels and DO2/VCO2 ratios during CPB. To
Table 1 Demographics and perioperative details of the
patient populationa
Factors Patient
data
(N = 359)
Age (years) - mean ± SD 66.1 ± 13.4
Gender male - number (%) 255 (71)
Weight (kg) - mean ± SD 77.2 ± 17.5
Body surface area (m2) - mean ± SD 1.91 ± 0.22
Baseline serum creatinine (mg/dL) - mean ± SD 1.14 ± 0.63
Estimated creatinine clearance (mL/minute) - mean ± SD 75.6 ± 31.7
Logistic EuroSCORE - mean ± SD 9.8 ± 14.1
Acute renal failure risk score [6] - mean ± SD 1.48 ± 0.98
Diabetes - number (%) 78 (22)
Chronic obstructive pulmonary disease - number (%) 37 (10)
Previous cerebrovascular accident - number (%) 32 (8.1)
Baseline haemoglobin value (g/dL) - mean ± SD 38 ± 4.7
Reoperation - number (%) 29 (8.1)
Isolated coronary operation - number (%) 170 (47)
Coronary plus valve operation - number (%) 74 (21)
Valve operation - number (%) 80 (22)
Other operations - number (%) 35 (10)
CPB duration (minutes) - mean ± SD 108 ± 44.6
Nadir temperature (°C) during CPB - mean ± SD 30.9 ± 3.1
Nadir haemoglobin value (mg/dL) during CPB - mean ±
SD
8.36 ± 1.28
Nadir hematocrit (%) during CPB - mean ± SD 25.1 ± 3.8
Nadir DO2 (mL/minute/m
2) during CPB - mean ± SD 278 ± 45
Peak VCO2 (mL/minute/m
2) during CPB - mean ± SD 52.5 ± 9.1
Nadir DO2/VCO2 ratio during CPB - mean ± SD 5.69 ± 1.1
Peak serum lactate (mmol/L) during CPB - mean ± SD 2.7 ± 0.98
Peak postoperative serum creatinine (mg/dL) - mean ± SD 1.56 ± 0.99
Peak postoperative creatinine change (%)- mean ± SD 39 ± 62
Nadir postoperative creatinine clearance (mL/minute) -
mean ± SD
62.1 ± 32.8
Acute kidney injury stage 1 - number (%) 31 (8.6)
Acute kidney injury stage 2 - number (%) 44 (12.2)
Any acute kidney injury - number (%) 75 (21)
Packed red blood cells transfusion (U) - median
(interquartile range)
1 (2)
ICU length of stay (days) - median (interquartile range) 1 (0)
Postoperative hospital stay (days) - median (interquartile
range)
5 (3)
aCPB: cardiopulmonary bypass; DO2: oxygen delivery; SD: standard deviation;
VCO2: carbon dioxide production.
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account for the role of the nadir HCT level during CPB
(as a component of both of the other variables), this
value was included in the analysis (Figure 3).
The best AUC was identified for the nadir DO2 level
(0.68), with slightly lower values for the nadir DO2/VCO2
ratio (0.62) and nadir the HCT level (0.61). The best cut-
off values according to the Youden’s index were set at a
nadir DO2 < 262 mL/minute/m
2, a nadir DO2/VCO2
ratio < 5.3 and a nadir HCT < 23.5%.
The multivariable analysis was performed with AKI
stage 2 rate and the rate of any kind of AKI as depen-
dent variables. For each model, nadir DO2 value and
nadir DO2/VCO2 ratio were separately analysed because
of mathematical coupling between the two variables.
The various factors identified in the univariate analysis
were tested for intercorrelation. There was a significant
intercorrelation between centres and EuroSCORE. Cen-
tre 1 included patients at significantly (P = 0.001) higher
risk for postoperative AKI (EuroSCORE 13.4 ± 17) than
centre 2 (EuroSCORE 4.1 ± 2.1). We therefore included
the EuroSCORE and not the centre in the multivariable
models. Some of the other univariate predictors of AKI
are included in the EuroSCORE (age, redo operations
and combined coronary and valve operation) and were
not included in the model to avoid multicollinearity.
In the multivariable model for AKI stage 2, we tested
the following variables: EuroSCORE, CPB duration,
number of PRC units transfused, nadir DO2 < 262 mL/
minute/m2 and nadir DO2/VCO2 ratio < 5.3. After cor-
rection for the other explanatory variables, both a nadir
Table 2 Bivariate association between perioperative factors, study variables and renal outcomesa
AKI stage 1 AKI stage 2 Any AKI
Variable b coefficient P value b coefficient P value b coefficient P value
Centre (1 or 2) 0.986 0.036b 2.034 0.001b 1.678 0.001b
Age (years) 0.049 0.011b 0.020 0.142 0.035 0.004b
Diabetes 0.762 0.057 0.346 0.345 0.611 0.037b
EuroSCORE 0.012 0.309 0.036 0.001b 0.034 0.001b
Reoperation -18.9 0.998 1.313 0.003b 0.565 0.183
CABG and valve operation 0.709 0.085 1.103 0.001b 1.104 0.001b
CPB duration (minutes) 0.006 0.910 0.009 0.001b 0.008 0.005b
PRCs transfusion (U) 0.103 0.288 0.221 0.004b 0.206 0.002b
Lowest HCT during CPB -0.075 0.147 -0.114 0.012b -0.111 0.003b
Nadir DO2 (mL/minute/m
2) -0.005 0.198 -0.012 0.001b -0.011 0.001b
Peak VCO2 (mL/minute/m
2) -0.052 0.014b 0.030 0.090 -0.005 0.743
Nadir DO2/VCO2 ratio 0.136 0.433 -0.408 0.010
b -0.192 0.119
aAKI: acute kidney injury; b: regression coefficient; CABG: coronary artery bypass graft; CPB: cardiopulmonary bypass; HCT: hematocrit; PRCs: packed red blood
cells; DO2: oxygen delivery; VCO2: carbon dioxide production;
bstatistically significant P values.
Figure 1 Graph showing acute kidney injury rate according to
decile distribution of nadir oxygen delivery (DO2) level during
cardiopulmonary bypass (CPB).
Figure 2 Acute kidney injury rate according to decile
distribution of nadir DO2/VCO2 ratio during CPB.
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DO2 < 262 mL/minute/m
2 and a nadir DO2/VCO2 ratio
< 5.3 during CPB remained independently associated
with AKI stage 2 rate (Table 3).
In the multivariable model for any kind of AKI, we
tested the following variables: diabetes, EuroSCORE,
number of PRC units transfused, CPB duration and
nadir DO2 during CPB < 262 mL/minute/m
2. After cor-
rection for the other explanatory variables, a nadir
DO2 < 262 mL/minute/m
2 during CPB remained inde-
pendently associated with the rate of any kind of AKI.
The cutoff values identified for the nadir DO2 and the
nadir DO2/VCO2 ratio during CPB were investigated
for their impact on the clinical patterns of AKI stage 2
(Figure 4). The patient group with a nadir DO2 value <
262 mL/minute/m2 during CPB had a significantly (P =
0.001) higher rate of postoperative AKI stage 2 (23.2%
vs. 7.4%), with a negative predictive value of 92.5%. The
patient group with a nadir DO2/VCO2 ratio < 5.3 dur-
ing CPB had a significantly (P = 0.001) higher rate of
AKI stage 2 (20% vs. 8%), with a negative predictive
value of 92%. The patient group with a nadir HCT <
23.5% had a significantly (P = 0.014) higher rate of AKI
stage 2 (18.5% vs. 9.4%).
As a secondary end point, we investigated the associa-
tion of the three study variables (nadir DO2, peak VCO2
and nadir DO2/VCO2 ratio during CPB) with the ICU
and postoperative hospital stays using linear regression
analysis. We found significant (P = 0.019 and P = 0.001,
respectively) negative associations between ICU length of
stay and postoperative hospital length of stay with nadir
DO2 during CPB. Conversely, there was no association of
ICU length of stay and postoperative hospital length of
stay with the peak VCO2 value and the nadir DO2/VCO2
ratio (Table 4). The previously identified cutoff value for
the nadir DO2 maintained its predictive power, being
associated with significant differences in both the ICU
and postoperative hospital lengths of stay, whereas the
cutoff value for the nadir DO2/VCO2 ratio had only a
trend for association with significant differences.
Discussion
AKI after cardiac surgery is one of the major determi-
nants of bad outcomes, with increased early and late
mortality rates and a considerable consumption of
human and financial resources. Many factors are impli-
cated in the complex mechanisms leading to postopera-
tive kidney function impairment, and unfortunately the
great majority are due to unmodifiable factors: advanced
patient age, preoperative renal dysfunction, diabetes,
hypertension, peripheral arteriopathy, chronic lung dis-
ease, complex surgery and other factors [2-6,16].
Figure 3 Receiver operating characteristic curves for acute
kidney injury stage 2 rate prediction based on nadir DO2 level,
nadir DO2/VCO2 ratio and nadir hematocrit (HCT) level.
Table 3 Multivariable stepwise forward logistic regression analysis for acute kidney injury and any damage-
independent predictorsa
Factor
Acute kidney injury severity b coefficient Odds ratio (95% CI) P value
Acute kidney injury stage 2
Model 1
EuroSCORE 0.034 1.035 (1.016 to 1.054) 0.001
CPB duration (minutes) 0.008 1.008 (1.002 to 1.015) 0.012
Nadir DO2 < 262 mL/minute/m
2 1.135 3.111 (1.531 to 6.319) 0.002
Model 2
EuroSCORE 0.035 1.036 (1.017 to 1.055) 0.001
CPB duration (minutes) 0.008 1.008 (1.002 to 1.014) 0.007
Nadir DO2/VCO2 ratio < 5.3 1.062 2.893 (1.452 to 5.763) 0.003
Any acute kidney injury
EuroSCORE 0.026 1.026 (1.008 to 1.045) 0.005
CPB duration (minutes) 0.009 1.009 (1.003 to 1.015) 0.004
Nadir DO2 < 262 mL/minute/m
2 0.767 2.154 (1.205 to 3.849) 0.010
aCPB: cardiopulmonary bypass; CI: confidence interval; DO2: oxygen delivery; VCO2: carbon dioxide production.
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Figure 4 Acute kidney injury rates in patient groups according to the critical values of DO2, DO2/VCO2 ratio and hematocrit, with
sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV).
Table 4 Univariate association (linear regression and Student’s t-test) between study variables and ICU and
postoperative hospital lengths of staya
Statistical analysis per variable
Variables b coefficient Constant P value
ICU length of stay (days)
Nadir DO2 (mL/minute/m
2) - 0.020 8.532 0.014
Peak VCO2 (mL/minute/m
2) 0.034 1.297 0.355
Nadir DO2/VCO2 ratio - 0.458 5.703 0.136
Postoperative hospital length of stay (days)
Factor b coefficient Constant P value
Nadir DO2 (mL/minute/m
2) - 0.055 29.39 0.001
Peak VCO2 (mL/minute/m
2) 0.001 14.15 0.996
Nadir DO2/VCO2 ratio - 0.516 17.02 0.428
Statistical analysis per cutoff value
Nadir DO2 < 262 mL/minute/m
2 Nadir DO2 ≥262 mL/minute/m
2 P value
ICU length of stay (days) 4.2 ± 8.7 2.5 ± 4.4 0.019
Postoperative hospital length of stay (days) 17.6 ± 14.1 12.4 ± 12.1 0.001
Nadir DO2/VCO2 ratio < 5.3 Nadir DO2/VCO2 ratio ≥5.3 P value
ICU length of stay length of stay (days) 3.4 ± 6.9 2.9 ± 5.6 0.476
Postoperative hospital length of stay (days) 15.3 ± 13.2 13.4 ± 12.6 0.198
aDO2: oxygen delivery; VCO2: carbon dioxide production.
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In the present study, we investigated the role of poten-
tially modifiable factors related to CPB surgery in deter-
mining postoperative AKI. Our results demonstrate, in a
relatively large series of patients treated at different sites,
that a low DO2 level and/or a low DO2/VCO2 ratio during
CPB are independently associated with postoperative AKI.
Given the nature of our study, we cannot confirm a causa-
tive relationship between DO2 and postoperative renal
function. We have identified specific cutoff values for both
DO2 (262 mL/minute/m
2) and DO2/VCO2 ratio (5.3), and
for both these values the negative predictive power
exceeds 90%. However, the measurement of CO2-related
variables did not increase the accuracy of the DO2-based
predictive model. In clinical terms, our data generate the
hypothesis that by maintaining the DO2 at a level > 262
mL/minute/m2 during CPB, the likelihood of experiencing
a postoperative AKI might be decreased.
Moreover, the cutoff value of 262 mL/minute/m2 as the
lowest acceptable DO2 during CPB is associated with sig-
nificant differences in terms of ICU and postoperative hos-
pital lengths of stay (about two and five days, respectively).
This study confirms some of the critical values pre-
viously identified in other studies [8,12,13]. Values of DO2
< 272 mL/minute/m2 during CPB have been associated
with an increased rate of acute renal failure [8], and values
< 260 mL/minute/m2 have been associated with increased
lactate formation [12].
It is well known that below a critical DO2 level, O2 con-
sumption cannot be maintained using aerobic energy
production, and that to provide energy to the cells, the
anaerobic mechanism is activated [17,18]. As a conse-
quence, blood lactate concentration starts rising, causing
excess proton production, and buffering of the protons
by bicarbonate results in increased VCO2. This mechan-
ism was identified for kidney tissue in 1966 [19]. Under
normothermic conditions in conscious humans [20], the
critical DO2 level is around 300 mL/minute/m
2. In our
study, we identified and confirmed that under anaesthesia
and moderate hypothermia, values as low as 262 mL/
minute/m2 can be sustained, but below this value kidney
function starts to decline.
The measurement of VCO2 -related variables did not
increase the accuracy of AKI prediction in our series.
VCO2 may increase even under normal aerobic condi-
tions, and during CPB this invariably happens during the
rewarming phase as a result of increased metabolic needs.
Theoretically, if coupled with the DO2 measurement
(DO2/VCO2 ratio), the measurement of VCO2 should
offer additional advantages for detecting dysoxia, as sug-
gested by other authors who demonstrated that CO2-
related variables, in combination with O2-related variables,
are good indicators of critical hypoperfusion [21,22].
Under our experimental conditions, no added value of
CO2-related variables was detected.
The results of our study, linking postoperative AKI to
a condition of ‘dysoxia’ during CPB, strengthen the
hypothesis that a condition of inadequate O2 supply
during CPB might lead to a hypoxic insult to the kidney,
as previously hypothesized by other authors who
demonstrated the relationship between a low Hb value
during CPB and bad renal outcomes [9-11].
Hb content and HCT level are physiological variables
that concur in the definition of the DO2. As such, they
have already been identified as independent predictors of
postoperative AKI [9-11]. In our study, we have confirmed
that the haemodilutional effects (nadir HCT during CPB)
are independently associated with postoperative AKI. The
nadir DO2 had a marginally higher accuracy in predicting
postoperative AKI, as suggested in a previous study [8],
but the respective roles of HCT and pump flow in deter-
mining postoperative AKI remain to be clarified, and spe-
cific randomized trials are required.
Kidney physiology and function are particularly depen-
dent on O2 supply. Under normal physiologic conditions,
peritubular capillaries are nourished by efferent glomerular
arteries [23], which carry poorly oxygenated blood, leading
to renal parenchymal hypoxia [24]. This effect is particu-
larly pronounced at the level of the renal medulla, with
partial pressure of O2 (pO2) levels as low as 25 mmHg
[25]. Therefore, it is not surprising that the kidney might
be one of the first organs to be affected with a global
reduction in DO2. In vitro studies have demonstrated that
some highly susceptible areas of the kidney are prone to
ischemic injury in cases of even slight reductions in renal
DO2 [26].
Reduced O2 content in cases of acute anaemia is
usually compensated by reduced blood viscosity with
increased blood flow in the microcirculation and by a
compensatory increase in cardiac output. This last
mechanism may be impaired during CPB, where pump
flow is usually adjusted on the basis of the patient’s
body surface area and temperature, not the Hb value.
Our study highlights some concepts related to post-
operative AKI prevention in cardiac surgery: (1) CPB is
one of the major determinants of AKI, and, in our analysis,
both CPB duration and the metabolic variables measured
during CPB were independent predictors of AKI; (2) oppo-
site to other determinants of postoperative AKI, DO2
belongs to the field of the modifiable risk factors; and (3)
the negative predictive value of the identified cutoff value
is very high, suggesting the potential clinical usefulness of
these values within a preemptive strategy of renal
protection.
Goal-directed strategies are key to improving artificial
heart and lung support during CPB. This is especially true,
given our more complex population with more comorbid-
ities than those in other studies. An effective goal-directed
strategy should be based on proven, clinically significant
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quality indicators such as DO2. Historically, it has been
difficult to deploy CPB goal-directed strategies because of
the limitations of parameters such as cardiac index, mean
arterial pressure, venous saturation, arterial blood tem-
perature, minimum Hb, partial pressure of CO2 and pO2.
The take-away message from our results is that the
maintenance of adequate DO2 may limit the risk of post-
operative AKI. To maintain an acceptable DO2, the pump
flow should be adjusted according to the Hb value of the
perfusate, not only according to the patient’s body surface
area and temperature. In other words, the pump should be
used to adjust the cardiac output exactly, as it happens as
a compensatory physiological mechanism during acute,
severe anaemia.
Our study has limitations. It lacked patients treated
under hypothermic conditions < 27°C, when different
limits of critical DO2 are likely to occur. The study is
not powered to detect other organs’ responses to low
DO2. Finally, this study was not a randomized, con-
trolled trial comparing a specific strategy (targeted at a
DO2 > 262 mL/minute/m
2) with conventional CPB
management.
Conclusions
The concept of goal-directed CPB perfusion merits
further investigations that are based on clinically signifi-
cant quality indicators such as DO2. This concept
should be tested for its clinical effects on kidney func-
tion and the function of other organs in an adequately
large, randomized, controlled trial.
Key messages
• A nadir DO2 < 262 mL/minute/m
2 during CPB is
independently associated with AKI stage 2 following
cardiac operations.
• Other determinants of AKI are patient age, the
presence of comorbidities, the type of operation (all
included in risk stratification scores such as the
EuroSCORE) and CPB duration.
• Nadir DO2 level is significantly associated with pro-
longed ICU and postoperative hospital lengths of stay.
• Goal-directed perfusion aimed at preserving DO2
during CPB (by reducing haemodilution and main-
taining high pump flow) should be tested as a possi-
ble preemptive strategy for postoperative AKI in a
randomized, controlled trial.
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